Drreddys Laboratories | RDY - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bayer EUR 4.5B 194M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Cipla INR 29.1B 1.16B 2025-12
Corcept Therapeutics USD 2.88M 338K 2026-03
Drreddys Laboratories INR 40.46B 3.64B 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Novartis USD 3.46B 83M 2026-03
Pacira USD 50.74M 3.89M 2026-03
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Richter Gedeon HUF 71.32B 1.01B 2025-09
Sun Pharmaceuticals INR 36.77B 348M 2025-12
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03